Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ENX-102 for social anxiety disorder has completed. The update notes evaluation of efficacy and safety, but no results are pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• ENX-102

Snippet

Sponsor: Engrail Therapeutics INC | Conditions: Social Anxiety Disorder (SAD) | Phase 2 | Status: COMPLETED